Nutritional risk index is a better predictor of early mortality than conventional nutritional markers after transcatheter aortic valve replacement: A prospective cohort study.
aortic valve stenosis
body mass index
hypoalbuminemia
transcatheter aortic valve replacement
Journal
Cardiology journal
ISSN: 1898-018X
Titre abrégé: Cardiol J
Pays: Poland
ID NLM: 101392712
Informations de publication
Date de publication:
2021
2021
Historique:
received:
05
12
2018
accepted:
27
03
2019
revised:
26
03
2019
pubmed:
18
4
2019
medline:
15
9
2021
entrez:
18
4
2019
Statut:
ppublish
Résumé
Nutritional risk index (NRI) has been shown to better predict survival than body mass index (BMI) or albumin after several cardiovascular interventions. Under assessment herein is whether NRI can have higher predictive value than conventional parameters for short-term survival after transcatheter aortic valve replacement (TAVR). A prospective cohort study was performed. In-hospital, 1-month and 3-month survival was evaluated. Since most patients undergoing TAVR are over 65, the NRI definition for a geriatric population (GNRI) was used. The impact of baseline BMI, albumin levels, and GNRI on in-hospital and short-term survival was assessed. One hundred fifty two patients aged 82 ± 5.4 were included. In-hospital, 1-month, and 3-month mortality was 5.3%, 5.9%, and 9.2%, respectively. Mean GNRI was 112.7 ± 11.9, and was significantly lower in patients who died in-hospital (101.0 ± 8.8 vs. 113.3 ± 11.7), at 30 days (103.4 ± 10.9 vs. 113.3 ± 11.7), and at 90 days (104.0 ± 9.6 vs. 113.6 ± 11.8) than in survivors (all, p < 0.05). Three-month mortality in patients with no nutritional risk was 6.8% (9/132) vs. 25% (5/20) in patients with malnutrition (p = 0.022). In univariate analysis, GNRI predicted in-hospital, 30-day, and 90-day mortality (all, p < 0.05). Predictive value remained significant after adjusting for age, EuroSCORE II, and STS-Score (p < 0.05). Based on receiver operating curves, GNRI (AUC: 0.73) showed a better discrimination for 3-month mortality than albumin (0.69), weight (0.67) or BMI (0.62). The optimal cut-off value was 109.8. The geriatric nutritional risk index predicts short-term mortality after TAVR and has a higher discriminating ability than other commonly used nutritional variables. It is a simple parameter that identifies those patients who could benefit from pre-procedural nutritional therapy.
Sections du résumé
BACKGROUND
Nutritional risk index (NRI) has been shown to better predict survival than body mass index (BMI) or albumin after several cardiovascular interventions. Under assessment herein is whether NRI can have higher predictive value than conventional parameters for short-term survival after transcatheter aortic valve replacement (TAVR).
METHODS
A prospective cohort study was performed. In-hospital, 1-month and 3-month survival was evaluated. Since most patients undergoing TAVR are over 65, the NRI definition for a geriatric population (GNRI) was used. The impact of baseline BMI, albumin levels, and GNRI on in-hospital and short-term survival was assessed.
RESULTS
One hundred fifty two patients aged 82 ± 5.4 were included. In-hospital, 1-month, and 3-month mortality was 5.3%, 5.9%, and 9.2%, respectively. Mean GNRI was 112.7 ± 11.9, and was significantly lower in patients who died in-hospital (101.0 ± 8.8 vs. 113.3 ± 11.7), at 30 days (103.4 ± 10.9 vs. 113.3 ± 11.7), and at 90 days (104.0 ± 9.6 vs. 113.6 ± 11.8) than in survivors (all, p < 0.05). Three-month mortality in patients with no nutritional risk was 6.8% (9/132) vs. 25% (5/20) in patients with malnutrition (p = 0.022). In univariate analysis, GNRI predicted in-hospital, 30-day, and 90-day mortality (all, p < 0.05). Predictive value remained significant after adjusting for age, EuroSCORE II, and STS-Score (p < 0.05). Based on receiver operating curves, GNRI (AUC: 0.73) showed a better discrimination for 3-month mortality than albumin (0.69), weight (0.67) or BMI (0.62). The optimal cut-off value was 109.8.
CONCLUSIONS
The geriatric nutritional risk index predicts short-term mortality after TAVR and has a higher discriminating ability than other commonly used nutritional variables. It is a simple parameter that identifies those patients who could benefit from pre-procedural nutritional therapy.
Identifiants
pubmed: 30994180
pii: VM/OJS/J/62070
doi: 10.5603/CJ.a2019.0038
pmc: PMC8078940
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
312-320Références
Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):274-280
pubmed: 27914696
Surg Oncol. 2017 Dec;26(4):483-488
pubmed: 29113668
Am J Cardiol. 2017 Mar 1;119(5):770-777
pubmed: 28017301
Ann Cardiothorac Surg. 2017 Sep;6(5):532-537
pubmed: 29062750
Clin Res Cardiol. 2018 Apr;107(4):304-311
pubmed: 29164390
J Am Geriatr Soc. 2017 Nov;65(11):2413-2417
pubmed: 28941287
Am J Cardiol. 2017 Jan 15;119(2):308-316
pubmed: 27839771
Nutr Metab Cardiovasc Dis. 2017 May;27(5):430-437
pubmed: 28438373
Clin Cardiol. 2015 Feb;38(2):76-81
pubmed: 25649013
Am J Cardiol. 2015 May 1;115(9):1260-4
pubmed: 25759105
EuroIntervention. 2016 Oct 10;12(8):e1057-e1064
pubmed: 27159658
Am J Cardiol. 2018 Jan 1;121(1):78-85
pubmed: 29103605
J Cardiovasc Surg (Torino). 2017 Feb;58(1):113-120
pubmed: 26939045
Am J Clin Nutr. 2005 Oct;82(4):777-83
pubmed: 16210706
Medicine (Baltimore). 2015 Nov;94(44):e1910
pubmed: 26554791
J Invasive Cardiol. 2017 Dec;29(12):431-436
pubmed: 29207365
Rev Esp Cardiol (Engl Ed). 2017 Aug;70(8):639-645
pubmed: 28209304
Neth Heart J. 2017 Sep;25(9):498-509
pubmed: 28536936
PLoS One. 2016 May 19;11(5):e0155903
pubmed: 27196126
EuroIntervention. 2016 Jan 22;11(9):1029-33
pubmed: 26384006
Am J Clin Nutr. 1988 Feb;47(2 Suppl):357-65
pubmed: 3124597
Am J Cardiol. 2017 Jun 1;119(11):1740-1745
pubmed: 28388993
Am Heart J. 2018 Aug;202:68-75
pubmed: 29883896
Aging Clin Exp Res. 2017 Apr;29(2):283-290
pubmed: 26980452
Circ J. 2018 May 25;82(6):1614-1622
pubmed: 29212959
Am J Cardiovasc Drugs. 2001;1(5):363-73
pubmed: 14728018
J Cardiol. 2017 Jan;69(1):383-388
pubmed: 27727086